Health professionals are encouraged to take the ESC Guidelines fully into account when
exercising their clinical judgment, as well as in the determination and the implementation of …

The prevalence of cardiometabolic disorders in both women and men has increased
worldwide and is linked to a rise in obesity and obesity-associated associated clustering of …

Objectives: Review the risk factors for coronary artery disease. Outline screening
recommendations for coronary artery disease. Identify diet and exercise recommendations …

Cardiovascular disease continues to be the leading cause of death among women in the
United States, accounting for≈ 1 of every 3 female deaths. Sex-specific data focused on …

Background Cardiovascular disease mortality rates are well known to be lower in women
than men and to increase with age. Whether these sex and age effects have changed over …

In the vast majority of cardiovascular diseases (CVDs), there are well-described differences
between women and men in epidemiology, pathophysiology, clinical manifestations, effects …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Background: Concerns exist that women are underrepresented in trials of cardiovascular
medications. Objectives: The authors sought to examine women's participation and the …

It is well known that cardiovascular disease manifests differently in women and men. The
underlying causes of these differences during the aging lifespan are less well understood …

Evolving knowledge of sex-specific presentations, improved recognition of conventional and
novel risk factors, and expanded understanding of the sex-specific pathophysiology of …